Colorectal Surgery Review

Join us for an evidence-based clinical deep dive into the 2024 American Society of Colon and Rectal Surgeons (ASCRS) Clinical Practice Guidelines for the Management of Pilonidal Disease.In this episode, we unpack the anatomical nuances, non-operative thresholds, and surgical algorithms needed to safely manage this chronic and often frustrating condition. We break down the stark paradigm shift away from traditional open excision towards tissue-sparing and off-midline approaches.(Please refer to the accompanying audio file: 2024_Guidelines_for_Inherited_Polyposis_Syndromes.m4a for the full discussion.)Key Clinical Topics Covered:Pathophysiology & Diagnostics: Understanding the acquired theory of pilonidal disease (hair insertion and follicular occlusion) versus congenital theories, and why routine imaging (ultrasound or MRI) is actively discouraged for primary disease.Acute Abscess Management: Why simple incision and drainage (I&D) remains the cornerstone of care, and why concurrent excision of the entire pilonidal cyst during an acute infection is contraindicated.Non-Operative Foundations: The critical role of perineal hygiene and hair removal. We discuss the striking downgrade of routine laser epilation and why conservative management is still favored for mild or asymptomatic disease.The Shift Away from Excision: The defining feature of the 2024 guidelines: the strong recommendation against traditional midline excision with primary closure due to unacceptably high recurrence and wound dehiscence rates.Tissue-Sparing Options: A detailed look at the mechanisms and success rates of minimally invasive procedures, including pit picking (Bascom I) and endoscopic pilonidal sinus treatment (EPSiT).Off-Midline Flap Closures: When to deploy complex flap closures for refractory or extensive disease. We break down the clinical utility of the Bascom Cleft Lift, the Karydakis flap, and the Limberg (rhomboid) flap.De-implemented Therapies: The lack of robust evidence supporting fibrin glue, phenol injection, and routine antibiotic prophylaxis in uncomplicated cases.

Welcome to Colorectal Surgery Review. In this episode, we deliver an evidence-based clinical breakdown of the 2023 American Society of Colon and Rectal Surgeons (ASCRS) Clinical Practice Guidelines for the Management of Familial Adenomatous Polyposis (FAP) and associated polyposis syndromes.Designed for practicing colon and rectal surgeons, surgical oncologists, and senior trainees preparing for board certification, this deep dive translates complex genetic data, anatomical considerations, and guideline algorithms into actionable surgical strategies.Key Clinical Topics Covered:Genetics & Pathophysiology: How APC gene mutations drive classical FAP, the concept of somatic mosaicism in attenuated FAP (AFAP), and the profound clinical implications of MUTYH-associated polyposis (MAP). We also discuss why 20-50% of patients presenting with an attenuated phenotype lack an identifiable pathogenic variant (the "genetic void"). Preoperative Staging & Extracolonic Disease: The critical shift to baseline upper endoscopy starting at age 20-25 to monitor for duodenal adenocarcinomas, which represent the leading cause of non-colorectal mortality in FAP. Surgical Timing & Prophylactic Colectomy: Why prophylactic surgery in classical FAP is typically delayed until the late teens or early 20s, balancing the 100% lifetime cancer risk against the psychosocial and functional burden of early intervention. The Surgical Triad: Detailed algorithmic decision-making between:Chemoprevention & Medical Management: The current (and often debated) role of NSAIDs (Sulindac) and COX-2 inhibitors (Celecoxib) in delaying polyp progression or managing retained rectal stump polyposis. Desmoid Tumors: The second leading cause of mortality in FAP patients. We explore why intra-abdominal surgical trauma often precipitates their aggressive growth and the modern shift toward non-operative, medical management of these challenging fibromatous lesions.

oin us for an evidence-based clinical review of the 2024 American Society of Colon and Rectal Surgeons (ASCRS) Clinical Practice Guidelines for the Management of Hemorrhoids.In this episode, we unpack the anatomical nuances, non-operative thresholds, and surgical algorithms needed to safely navigate one of the most common—yet frequently mismanaged—anorectal conditions. We delve into the shifting consensus around office-based therapies and examine the dramatic downgrade of stapled hemorrhoidopexy.(Please refer to the accompanying audio file: New_ASCRS_Colon_Cancer_Surgical_Guidelines.m4a for the full discussion.)Key Clinical Topics Covered:Anatomy & Pathophysiology: How the degradation of suspensory ligaments and vascular engorgement drive disease progression, and why the dentate line dictates symptom presentation.Non-Operative Foundations: The critical role of bulk-forming fiber and hydration. We discuss why topical steroids and topical anesthetics are actively discouraged for long-term use due to mucosal atrophy and allergic contact dermatitis.Office-Based Interventions (Grades I–II):Surgical Management (Grades III–IV):Special Populations & Emergencies:

The newly published 2025 ASCRS guidelines for appendiceal neoplasms represent a total departure from traditional surgical dogma, revealing a 16% risk of concealed malignancy in patients presenting with periappendiceal abscesses. This mandates strict oncologic follow-up after initial antibiotic therapy and percutaneous drainage.Beyond the appendix, this episode explores the etiology, staging, and treatment algorithms for anal squamous cell carcinoma. Driven by HPV (specifically serotypes 16 and 18) within the anal transitional zone (ATZ), anal cancer requires a distinct management approach far different from colorectal adenocarcinoma.

Welcome to Colorectal Surgery Review. In this episode, we deliver a high-yield clinical breakdown of the American Society of Colon and Rectal Surgeons (ASCRS) Clinical Practice Guidelines for the Management of Colon Cancer.Designed for practicing colon and rectal surgeons, surgical oncologists, general surgeons, and senior trainees preparing for board certification or recertification exams, this deep dive translates complex trial data, molecular insights, and guideline recommendations into actionable clinical decision-making.

Join us for an in-depth clinical review of the 2022 American Society of Colon and Rectal Surgeons (ASCRS) Clinical Practice Guidelines for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula.In this episode, we break down the latest evidence-based algorithms, anatomical pearls, surgical techniques, and clinical pitfalls needed for surgical practice and board exam preparation.

Join us for a comprehensive clinical review of the American Society of Colon and Rectal Surgeons (ASCRS) Clinical Practice Guidelines for the Management of Anal Fissures.In this episode, we move beyond basic definitions to examine the vascular mechanics, randomized trial data, and surgical algorithms needed to break the cycle of internal sphincter hypertonia and ischemia. Whether you are updating your clinical practice or prepping for board exams, this evidence-based review delivers high-yield insights.

A clinical deep dive into the 2022 and 2023 ASCRS and SAGES guidelines for Enhanced Recovery After Surgery (ERAS). We cover carbohydrate loading, bowel prep, SSI bundles, fluid management, the NSAID leak debate, and early discharge.Join us for an evidence-based clinical review of the 2022 and 2023 American Society of Colon and Rectal Surgeons (ASCRS) and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Clinical Practice Guidelines for Enhanced Recovery After Surgery (ERAS).In this episode, we move past basic ERAS concepts to explore the precise physiological mechanisms, statistical realities, and trial data driving modern perioperative care. Whether you are updating hospital protocols or prepping for your board exams, this review delivers the high-yield details you need.

Join us for a detailed clinical dissection of the updated American Society of Colon and Rectal Surgeons (ASCRS) and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Clinical Practice Guidelines for Enhanced Recovery After Surgery (ERAS).In this episode, we move past basic ERAS concepts to explore the precise physiological mechanisms, statistical realities, and trial data behind modern perioperative pathways. Whether you are updating hospital protocols, optimizing patient pathways, or prepping for recertification and board exams, this review delivers the evidence-based details you need.Preoperative Optimization & Stoma Education: Implementing structured ileostomies pathways to prevent dehydration and AKI—reducing readmission rates from 15.5% down to 0%.Fasting & Carbohydrate Loading: Ditching the "NPO after midnight" rule for clear liquids up to 2 hours pre-induction. Why complex carbohydrates (maltodextrin) prevent post-op insulin resistance and why simple sugars are avoided.Pre-op Nutrition vs. Immunonutrition: Weight-based protein supplementation (1.2–1.5 g/kg/day) for malnourished patients and why commercial immunonutrition shakes remain controversial in non-industry-funded trials.Bowel Prep & C. diff Reduction: The strong Grade 1B mandate for combining Mechanical Bowel Preparation (MBP) with oral antibiotics (Neomycin + Metronidazole/Erythromycin) to decimate mucosal biofilms and cut SSIs in half.Intraoperative SSI Bundles: Swiss-cheese risk management, including dedicated wound-closure trays, mandatory glove/gown changes before facial closure, normothermia, and tight glycemic control.Analgesia & The NSAID Leak Debate: Why Diclofenac dramatically increases anastomotic leak rates due to enterohepatic circulation, while Ketorolac and COX-2 inhibitors remain safe. Plus, why routine thoracic epidurals and gabapentinoids are falling out of favor in minimally invasive cases.Fluid Management & Hemodynamics: Moving away from "bone-dry" fluid restriction to preserve the endothelial glycocalyx. The chemistry of why Normal Saline causes hyperchloremic metabolic acidosis and renal vasoconstriction, and how Goal-Directed Hemodynamic Therapy (GDHT) prevents fluid overload.Hardware & Post-Op Care: Evidence against routine NG tubes and pelvic drains, accepting post-op oliguria down to 0.2 mL/kg/hr without fluid boluses, and accelerating bowel return with sham feeding (gum) and coffee.Early Discharge Pathways: Criteria from the RECOVER MI trial allowing selected low-risk patients to safely go home on Post-Op Day 1 before the return of bowel function.

Join us for a detailed clinical breakdown of the 2018 American Society of Colon and Rectal Surgeons (ASCRS) Clinical Practice Guidelines for Anal Squamous Cell Cancer. In this episode, we dive into the virology, staging nuances, landmark trial data, and treatment paradigms every practicing surgeon, oncologist, and board candidate needs to master.Key Topics Covered in This Episode:Etiology & Risk Factors: The oncogenic role of HPV (serotypes 16 & 18), the field defect within the anal transitional zone (ATZ), and independent risk factors such as cigarette smoking and immunosuppression.Anatomic Classification: Distinguishing anal canal vs. perianal lesions using gluteal distraction and the strict 5 cm distance rule.Pathology & Biomarkers: Implementing the LAST two-tiered terminology (LSIL vs. HSIL), why the term "Bowen's disease" is obsolete, and using p16 and Ki-67 biomarkers to guide diagnosis.Screening & High-Resolution Anoscopy (HRA): Addressing the low specificity of anal cytology swabs, the mechanism of aceto-white staining during HRA, and when expectant management is acceptable.HPV Vaccination Rule: Why secondary HPV vaccination is not recommended for treating existing dysplasia (Grade 2A).Staging Pitfalls: Why anal SCC staging relies on maximum diameter rather than depth of wall invasion, and why sphincter muscle invasion does not upgrade a tumor to T4.Definitive Chemoradiation (The Nigro Protocol): The shift away from primary APRs, radiation dosing limits, and trial evidence (RTOG 9811 & ACT II) proving why 5-FU + Mitomycin C remains superior to Cisplatin.Surgical Exceptions & Survivorship: Narrow criteria for wide local excision alongside essential pre-treatment counseling for fertility preservation and post-radiation vaginal stenosis.